Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (50)
Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 0:0, pages 1-19.
Read now
Read now
Christian Gessner, Frederik Trinkmann, Sanaz Bahari Javan, Raimund Hövelmann, Valentina Bogoevska, George Georges, Elena Nudo & Carl-Peter Criée. (2022) Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3019-3031.
Read now
Read now
Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald & Claus F Vogelmeier. (2022) Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2355-2367.
Read now
Read now
Sanjay Sethi, Antony Wright, Elisabeth Sophia Hartgers-Gubbels, Marlene Hechtner, Brendan Clark, Ciara Wright, Sue Langham & Roland Buhl. (2022) Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2149-2160.
Read now
Read now
Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Read now
Lili Jiang, Tetyana Kendzerska, Shawn D. Aaron, Therese A. Stukel, Matthew B. Stanbrook, Wan Tan, Priscila Pequeno & Andrea S. Gershon. (2022) Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 315-323.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen & Wen-Chien Cheng. (2021) A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1555-1568.
Read now
Read now
Kjell Larsson, Ann Ekberg-Jansson, Caroline Stridsman, Malin Hanno & Lowie E G W Vanfleteren. (2021) Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 909-918.
Read now
Read now
John R Hurst, Mohd Kashif Siddiqui, Barinder Singh, Precil Varghese, Ulf Holmgren & Enrico de Nigris. (2021) A Systematic Literature Review of the Humanistic Burden of COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1303-1314.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila & Sarah H Landis. (2021) Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1255-1264.
Read now
Read now
Fernando J Martinez, Gary T Ferguson, Eric Bourne, Shaila Ballal, Patrick Darken, Magnus Aurivillius, Paul Dorinsky & Colin Reisner. (2021) Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 179-189.
Read now
Read now
Edward Kerwin, Gregory Feldman, James Pearle, Luis De La Cruz, Melinda Edwards, Carolyn Beaudot & George Georges. (2021) Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 181-190.
Read now
Read now
Marco Contoli, Luca Morandi, Fabiano Di Marco & Mauro Carone. (2021) A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment. Expert Opinion on Pharmacotherapy 22:4, pages 427-437.
Read now
Read now
Paola Rogliani, Beatrice Ludovica Ritondo, Mariachiara Gabriele, Mario Cazzola & Luigino Calzetta. (2020) Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings. Expert Review of Clinical Pharmacology 13:9, pages 977-990.
Read now
Read now
Takeo Suzuki, Jolyon Fairburn-Beech, Keiko Sato & Toshihiko Kaise. (2020) Clinical characteristics, treatment patterns, disease burden, and persistence/adherence in patients with asthma initiating inhaled triple therapy: real-world evidence from Japan. Current Medical Research and Opinion 36:6, pages 1049-1057.
Read now
Read now
Wen-Chien Cheng, Biing-Ru Wu, Wei-Chih Liao, Chih-Yu Chen, Wei-Chun Chen, Te-Chun Hsia, Chih-Yen Tu, Chia-Hung Chen & Wu-Huei Hsu. (2020) When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3375-3384.
Read now
Read now
Jennifer K Quint, Alessandra Venerus, Caroline O’Leary, Melissa Myland, Ulf Holmgren, Precil Varghese & Claudia Cabrera. (2020) Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3261-3271.
Read now
Read now
Konstantinos Kostikas, David Price, Florian S Gutzwiller, Bethan Jones, Emil Loefroth, Andreas Clemens, Robert Fogel, Rupert Jones & Hui Cao. (2020) Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1729-1738.
Read now
Read now
Chloe I Bloom, Ian Douglas, Omar S Usmani & Jennifer K Quint. (2020) Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 701-710.
Read now
Read now
Fabian A Grewe, Noriane A Sievi, Matteo Bradicich, Maurice Roeder, Thomas Brack, Martin H Brutsche, Martin Frey, Sarosh Irani, Jörg D Leuppi, Robert Thurnheer, Christian F Clarenbach & Malcolm Kohler. (2020) Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 627-635.
Read now
Read now
Gary T Ferguson, Asif Shaikh, Kay Tetzlaff, Achim Mueller, Helgo Magnussen & Henrik Watz. (2020) Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2879-2888.
Read now
Read now
Claudio Tantucci & Laura Pini. (2020) Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 821-829.
Read now
Read now
Chloe I Bloom, SL Elkin & JK Quint. (2019) Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 279-287.
Read now
Read now
Jørgen Vestbo, Claus F Vogelmeier, Mark Small, James Siddall, Robert Fogel & Konstantinos Kostikas. (2019) Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 853-861.
Read now
Read now
Michael Bogart, Richard H Stanford, François Laliberté, Guillaume Germain, Jennifer W Wu & Mei Sheng Duh. (2019) Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 343-352.
Read now
Read now
S Gaduzo, V McGovern, J Roberts, JE Scullion & D Singh. (2019) When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 391-401.
Read now
Read now
Maciej Kupczyk & Piotr Kuna. (2019) Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 13:1, pages 5-11.
Read now
Read now
Antonio Molino, Giovanna Calabrese & Mauro Maniscalco. (2018) Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol. Patient Preference and Adherence 12, pages 993-1001.
Read now
Read now
Lowie Vanfleteren, Leonardo M Fabbri, Alberto Papi, Stefano Petruzzelli & Bartolome Celli. (2018) Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3971-3981.
Read now
Read now
Zuzana Diamant, Guy Brusselle & Richard E Russell. (2018) Toward effective prescription of inhaled corticosteroids in chronic airway disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3419-3424.
Read now
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Read now
Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus F Vogelmeier, Konstantinos Kostikas, Nadine S Lossi & Heinrich Worth. (2018) Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2557-2568.
Read now
Read now
Didier Cataldo, Eric Derom, Giuseppe Liistro, Eric Marchand, Vincent Ninane, Rudi Peché, Hans Slabbynck, Walter Vincken & Wim Janssens. (2018) Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2089-2099.
Read now
Read now
Jose Luis Lopez-Campos, Bernardino Alcázar Navarrete, Joan B Soriano, Juan J Soler-Cataluña, José Miguel Rodríguez González-Moro, Manuel E Fuentes Ferrer & Myriam Calle Rubio. (2018) Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2279-2288.
Read now
Read now
Alejandro Casas, Maria Montes de Oca, Ana MB Menezes, Fernando C Wehrmeister, Maria Victorina Lopez Varela, Laura Mendoza, Larissa Ramírez & Marc Miravitlles. (2018) Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1545-1556.
Read now
Read now
John R Hurst, Maria Dilleen, Kevin Morris, Siân Hills, Birol Emir & Rupert Jones. (2018) Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 781-792.
Read now
Read now
Tomoko Betsuyaku, Motokazu Kato, Keisaku Fujimoto, Akihiro Kobayashi, Tomoyuki Hayamizu, Hideki Hitosugi, Gerald Hagan, Mark H James & Paul W Jones. (2018) A randomized trial of symptom-based management in Japanese patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2409-2423.
Read now
Read now
Amnon Ariel, Alan Altraja, Andrey Belevskiy, Piotr W Boros, Edvardas Danila, Matjaz Fležar, Vladimir Koblizek, Zvi G Fridlender, Kosta Kostov, Alvils Krams, Branislava Milenkovic, Attila Somfay, Ruzena Tkacova, Neven Tudoric, Ruxandra Ulmeanu & Arschang Valipour. (2018) Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 45-56.
Read now
Read now
Javier Mohigefer, Carmen Calero-Acuña, Eduardo Marquez-Martin, Francisco Ortega-Ruiz & Jose Luis Lopez-Campos. (2018) Understanding of COPD among final-year medical students. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 131-139.
Read now
Read now
Mario Cazzola, Paola Rogliani, Ermanno Puxeddu, Josuel Ora & Maria Gabriella Matera. (2018) An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Review of Respiratory Medicine 12:1, pages 43-54.
Read now
Read now
Raquel Marçôa, Daniela Marta Rodrigues, Margarida Dias, Inês Ladeira, Ana Paula Vaz, Ricardo Lima & Miguel Guimarães. (2018) Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:1, pages 21-26.
Read now
Read now
Mike Thomas, David MG Halpin & Marc Miravitlles. (2017) When is dual bronchodilation indicated in COPD?. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2291-2305.
Read now
Read now
Bo Ding, Mark Small & Ulf Holmgren. (2017) A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1527-1537.
Read now
Read now
Claus Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Nadine S Lossi, Claudia Mailänder & Peter Kardos. (2017) “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 487-494.
Read now
Read now
Didier Cataldo, Jean-Louis Corhay, Eric Derom, Renaud Louis, Eric Marchand, Alain Michils, Vincent Ninane, Rudi Peché, Charles Pilette, Walter Vincken & Wim Janssens. (2017) A Belgian survey on the diagnosis of asthma–COPD overlap syndrome. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 601-613.
Read now
Read now
Joan B. Soriano. (2017) An Epidemiological Overview of Chronic Obstructive Pulmonary Disease: What Can Real-Life Data Tell Us about Disease Management?. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:sup1, pages S3-S7.
Read now
Read now
Sarah H. Landis, Keele Wurst, Hoa Van Le, Kerina Bonar & Yogesh S. Punekar. (2017) Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:1, pages 80-85.
Read now
Read now
Pavlina A. Andreeva-Gateva, Eleonora Stamenova & Tzvetelin Gatev. (2016) The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review. Postgraduate Medicine 128:5, pages 474-484.
Read now
Read now
Articles from other publishers (7)
Claus F. Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Eva Gückel & Peter Kardos. (2022) Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study. Respiratory Research 23:1.
Crossref
Crossref
Antony Wright, Helene Vioix, Shamika de Silva, Sue Langham, Jennifer Cook, Toby Capstick & Jennifer K Quint. (2022) Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK. BMJ Open 12:6, pages e059158.
Crossref
Crossref
S. N. Avdeev, V. A. Nevzorova, L. M. Kudelya, N. M. Kondrashova, G. I. Sukhanova, M. F. Kinyaykin, I. V. Naumova & A. G. Shkuratov. (2019) Issues of triple therapy of chronic obstructive pulmonary disease. Comments to the algorithm. A resolution of expert panel, June 13, 2018, Vladivostok. Russian Pulmonology 29:3, pages 365-374.
Crossref
Crossref
J. Sehl, J. O’Doherty, R. O’Connor, B. O’Sullivan & A. O’Regan. (2017) Adherence to COPD management guidelines in general practice? A review of the literature. Irish Journal of Medical Science (1971 -) 187:2, pages 403-407.
Crossref
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Crossref
E. N. Barabanova. (2017) GOLD 2017: what change were made in global strategy of treatment of chronic obstructive pulmonary disease and why?. PULMONOLOGIYA 27:2, pages 274-282.
Crossref
Crossref
Štefan Laššán, Monika Laššánová, Jana Tisoňová & Peter Krištúfek. (2016) Summary. Klinická farmakologie a farmacie 30:1, pages 22-29.
Crossref
Crossref